newsfilter
← Latest News
PR Newswire·

Compugen to Present Research at the Single Cell Genomics 2025 Conference

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery,...